Optimi Health Corp. (CSE:OPTI)

Market Cap	20.61M -30.1%
Revenue (ttm)	175.67K -68.0%
Net Income	-6.90M
EPS	-1.98
Shares Out	5.73M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,413
Open	3.650
Previous Close	3.620
Day's Range	2.960 - 3.650
52-Week Range	2.940 - 12.150
Beta	1.57
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 11, 2026

About Optimi Health

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2020
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: OPTI

Financial Performance

In fiscal year 2025, Optimi Health's revenue was 426,301, an increase of 9.35% compared to the previous year's 389,850. Losses were -3.71 million, -38.50% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error